アクセシビリティに関する当社の声明を見るにはクリックしてください

人気の検索

灰色の短髪にダークグレーのブレザー、水色のシャツを着た男性が、ぼやけた室内オフィスの背景に立ち、微笑んでいる——シカゴの訴訟支援専門弁護士たちのプロフェッショナリズムを映し出している。

アニル・シャンカール

パートナー

戻る

アニル・シャンカール

パートナー

Los Angeles 213.972.4584

セクター

取扱分野

教育

  • New York University School of Law (J.D., 2008)
  • Stanford University (M.A., 2001)
  • University of California, Los Angeles (B.A., 2000)

入学

  • カリフォルニア

アニル・シャンカールは、フォーリー・アンド・ラードナー法律事務所のパートナーであり、医療分野の弁護士として同事務所の医療法務グループに所属している。医療提供者が複雑な規制や償還問題に対処する際の戦略的助言を提供しており、特にメディケイドプログラムとセーフティネット提供者に影響を与える課題に重点を置いている。

Anil has been recognized by Chambers USA: America’s Leading Business Lawyers:

““He’s smart, patient and always comes up with creative solutions to complicated problems.”

“We often ask Anil to work on thorny issues that he parses with sophistication and nuance that is essential to solving problems.”

Anil is a lecturer at the UCLA School of Law, where he teaches Health Care Compliance.

Medicaid Experience

Anil advises hospitals, clinics, health systems, other providers, managed care plans, and governmental entities on their participation in Medicaid programs. He has helped develop innovative new programs, including Medicaid supplemental payments, quality networks, state and local provider taxes or assessments, and public-private partnerships. He has extensive experience in the use of health care funding to address the social determinants of health and helped to design and implement California’s Whole Person Care pilots, which operate innovative programs for individuals experiencing homelessness, individuals leaving incarceration, individuals with significant mental health disorders, and other vulnerable populations.

He advises clients on a numerous Medicaid reimbursement and compliance issues, including overpayment investigations and analyses. He has also assisted numerous companies seeking to enter into the Medicaid program. Anil also has deep knowledge of Medicaid managed care and has helped plans and providers evaluate regulatory changes and structure alternative payment methodologies to meet their goals.

340B Drug Pricing Program

Anil heads the firm’s robust 340B Drug Pricing Program practice, which counsels hospital systems, federally qualified health centers, and federal grantees with regard to their obligations and opportunities under the program. He advises clients on compliance and overpayment issues, self-disclosures, internal and governmental audits, 340B contracting, and has helped to restructure entities to maximize 340B Program savings.

行動健康

Anil has extensive experience advising clients on behavioral health reimbursement, operational, and compliance issues. He has counseled hospitals on health systems seeking to expand their behavioral health offerings, including strategic counseling to avoid licensing, regulatory, and reimbursement pitfalls. In addition, Anil has helped design systems to protect and share confidential patient information, including behavioral health information. He works with local behavioral health directors, providers, and managed delivery systems on issues related to funding, reimbursement, program development, and strategic implementation.

Auditing and Compliance

Anil advises health care providers and companies to track and oversee federal grants and reimbursement, including hemophilia treatment center funds, Ryan White funds, 340B funds, FQHCs, and has advised them during related audits. During the coronavirus pandemic, Anil advised hospitals, health systems, governmental entities, nursing facilities and other health care providers and companies with regard to their application, receipt and use of federal relief funds, including the Provider Relief Fund and Coronavirus Relief Fund.  He has recovered millions of dollars by successfully challenging Medicaid reimbursement audit findings.

受賞歴と表彰

  • Chambers USA, Health Care Law (2022 and 2024)

所属

  • Faculty lecturer at the UCLA School of Law
  • 米国医療法弁護士協会会員
  • ロサンゼルス郡弁護士会（医療法部門）会員
  • アメリカ法曹協会（医療法部門）会員

出版物と発表

  • 共著者、「カリフォルニア州機関が高額病院への取り締まりを強化」、『ヘルスケア・ロー・トゥデイ』（2025年5月6日）
  • Co-author, “The 340B Drug Pricing Program: Top Five Things to Know,” Health Care Law Today (September 17, 2024)
  • Co-speaker, “Strategies for Working with and Discharging Homeless Populations,” Hospital Association of Southern California’s 2024 Annual Meeting (May 21, 2024)
  • Author, “Medicaid: CMS Final Rules Aim to Expand Access, Provide Parity with Commercial Markets,” Health Care Law Today (May 13, 2024)
  • Co-author, “Health-Related Social Needs: Three Trends in Leveraging Community Partnerships,” Health Care Law Today (March 27, 2024)
  • Co-author, “CMS Proposes Remedy for 340B-Acquired Drug Payment Policy for CY 2018-2022,” Health Care Law Today (July 26, 2023)
  • Co-author, “The Future of the 340B Program: 2023 Key Decisions,” Health Care Law Today (March 30, 2023)
  • Co-speaker, “Social Determinants of Health,” What You Need to Know About Payor/Provider Convergence (Jan 26, 2023)
  • Moderator, “The Urgency of Behavioral Health Integration and Whole Person Care,” Moss Adams Conference (Nov. 3, 2022)
  • Author, “California Moves to Transform the Behavioral Health Delivery System – Are Payers and Providers Ready?,” Health Care Law Today (Oct. 31, 2022)
  • Co-author, “340B Hospitals Win in Medicare OPPS Supreme Court Decision,” Health Care Law Today (June 21, 2022)
  • Co-speaker, “Strategies for Difficulty to Discharge Patients,” California Association of Public Hospitals member meeting (December 8, 2021)
  • Presenter, “PRF Reporting,” California Association of Public Hospitals and Health Systems member meeting (September 16, 2021)
  • Co-author, “Payment Dispute with a Medicaid Health Plan? State Not Obligated to Help, According to Federal Court,” Health Care Law Today (July 14, 2021)
  • Co-author, “Court Sides with Drug Manufacturers in Ongoing 340B Litigation,” Health Care Law Today (June 22, 2021)
  • Co-author, “HHS Extends Timeline for Spending Provider Relief Fund,” Health Care Law Today (June 14, 2021)
  • Co-author, “Congress Requires New Medicaid Payment Reporting,” Health Care Law Today (February 23, 2021)
  • Co-author, “Congress Overrides HHS Guidance on Use of Provider Relief Funds,” Health Care Law Today (January 11, 2021)
  • Co-author, “New HHS Board will Hear 340B Drug Pricing Disputes,” Health Care Law Today (December 15, 2020)
  • Co-author, “COVID-19: Provider Relief Fund General Distribution – Phase 3,” Health Care Law Today (October 5, 2020)
  • Co-author, “COVID-19: HHS Publishes Long-awaited Reporting Requirements for Provider Relief Fund Recipients,” Health Care Law Today (September 23, 2020)
  • Co-author, “COVID-19: Take Two (for some) on Additional DHHS Provider Relief Funding,” Health Care Law Today (August 12, 2020)
  • Co-presenter, “COVID-19 Provider Relief Funds – Use of Funds, Attestations, and Risk Analysis,” Foley & Lardner LLP Web Conference (April 28, 2020)
  • Co-author, “COVID-19: Understanding HHS’s Plans to Disperse Provider Relief Funds Authorized By The CARES Act,” Health Care Law Today (April 27, 2020)
  • Co-author, “COVID-19: Federal Agencies Prepare to Distribute Unprecedented Federal Financial Relief for the Health Care Industry,” Health Care Law Today (March 30, 2020)
  • Co-author, “CMS Proposes Enhanced Scrutiny over Medicaid Supplemental Payments,” Health Care Law Today (November 20, 2019)
  • Co-author, “Voluntary Behavioral Health Integration in Medi-Cal: What Can be Achieved under Current Law,” California Health Care Foundation (October 21, 2019)
  • Co-author, “Off-Campus Hospital Outpatient Departments Take Another Hit in CMS Final Rule,” Health Care Law Today (November 14, 2018)
  • Co-author, “A Novel Strategy for Increasing Access to Treatment for Hepatitis C Virus Infection for Medicaid Beneficiaries,” Annals of Internal Medicine (July 17, 2018)
  • Co-author, “Policy Brief: A novel strategy for increasing access to Hep C treatment for Medicaid beneficiaries,” USC-Brookings Schaeffer Initiative for Health Policy (May 2018)
  • Co-author, “California: Proposed Legislation Regulating Health Care Rates for Payors and Providers,” Health Care Law Today (April 19, 2018)
  • Co-author, “California Medicaid Agency Proposes Significant Restrictions on FQHC and RHC Reimbursement,” Health Care Law Today (March 13, 2018)
  • Co-author, “SAMHSA Finalizes Second Round of Changes to Federal Substance Use Disorder Privacy Rule,” Health Care Law Today (January 11, 2018)
  • Co-author, “Ninth Circuit Victory Opens Door to Medicaid Reimbursement Challenges Based on Equal Access Requirement,” AHLA Bulletin (August 2017)
2025年10月16日 ニュースで

フォーリー法律事務所、メディケイドに対するH.R.1法案の抜本的変更を概説

フォーリー・アンド・ラーダー法律事務所のアニル・シャンカールパートナーとパブリックアフェアーズディレクターのジェニファー・ウォルシュは、医療イノベーション記事「H.R. 1とメディケイド：医療提供者が知っておくべき今後の変更点」において、最近開催した医療ウェブセミナーが取り上げられた。
2025年10月15日 イベント

H.R.1法案がメディケイド予算を削減した経緯：これがあなたに与える影響

2025年7月4日に成立した新たな連邦予算法H.R.1は、メディケイドおよびその他の政府医療プログラムに劇的な変更をもたらす。これには、特定の移民に対する受給資格の重大な新規制限、メディケイド適用拡大により低所得成人をカバーすることを選択した州に適用される新規要件、ならびにメディケイドプログラムの資金調達に関する抜本的な変更が含まれる。
注目の画像
2025年7月29日 今日の医療法

非適格外国人（非資格外国人）を連邦プログラムから除外するHHSガイダンスが、提供者と助成金受給者に疑問を投げかける

2025年7月14日付の通知により、非適格外国人に対して適用される12の新規連邦公的給付プログラム（下記参照）が特定された。
メディケイドの受給資格に関する情報と聴診器。
2025年7月17日 今日の医療法

一つの巨大で美しい法案：予算削減がメディケイド計画を混乱させる

2025年7月4日に制定された新たな連邦予算法「ワン・ビッグ・ビューティフル・ビル法」（本法）は、メディケイドに劇的な変更をもたらす...
夕暮れ時のアメリカ合衆国最高裁判所ビル（ワシントンD.C.）
2025年7月1日 今日の医療法

性別適合医療：最高裁のスクルメッティ判決が全国の医療提供者に意味するもの

2025年6月18日、米国最高裁判所は合衆国対スクルメッティ事件において重要な判決を下し、テネシー州による...の禁止を認めた。
2025年6月5日 プレスリリース

フォーリー、Chambers USA 2025で最高位を獲得

フォーリー・アンド・ラーダーナー法律事務所は、2025年版『Chambers USA: America’s Leading Lawyers for Business』において、国内を代表する法律事務所の一つとして再びチェンバース・アンド・パートナーズに選出されたことを誇りに思います。
すべてのインサイトを表示
ニュースルームを見る